Clinical Updates on Atopic Dermatitis Treatment
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Dermatology".
Deadline for manuscript submissions: closed (30 November 2024) | Viewed by 3929
Special Issue Editor
Special Issue Information
Dear Colleagues,
Atopic dermatitis (AD) is one of the common chronic inflammatory skin diseases worldwide, with pruritus as a primary lesion. Although AD is most often diagnosed in childhood, many adults experience the disease even after the age of 18. AD is associated with multiple triggers and mechanisms; thus, the treatment of AD is complex, and many drugs and therapeutic targets are given. The main current strategies to treating AD are daily skincare used to moisturize and improve the cutaneous barrier dysfunction and medical treatments taken to control the itching and inflammation. However, it is hard to keep AD patients in remission. Recently systemic treatments, such as Janus kinase inhibitors and interleukin receptor inhibitors, have proven efficacious in AD. The aim of this Special Issue is to provide a comprehensive overview of advances in the diagnosis and treatment of AD, with particular interest on the use of innovative techniques and technologies in interventional therapies. Therefore, researchers in the field of AD are encouraged to submit their findings as original articles or reviews to this Special Issue.
Prof. Dr. Yutaka Takagi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- skincare
- proactive therapy
- calcineurin inhibitors
- systemic treatment
- biologics
- pediatrics
- pruritus
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
